These findings provide important new insights into understanding the roles that HA-CD44-mediated PKCε activation and Nanog-regulated miR-21 play in regulating anti-apoptosis and chemotherapy resistance in breast tumor cells. This evidence concerns the gene NANOG and breast neoplasm.